ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Balance Sheet
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's total assets for Q4 2024 were ¥922.00M, a decrease of 0.00% from the previous quarter. HK:1541 total liabilities were ¥243.69M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24
Dec 23
Dec 22
Dec 21
Total Assets
¥ 922.00M
¥ 874.59M
¥ 839.98M
¥ 892.84M
Total Liabilities
¥ 243.69M
¥ 126.30M
¥ 60.76M
¥ 2.49B
Total Equity Gross Minority
¥ 678.30M
¥ 748.29M
¥ 779.22M
¥ -1.60B
Other Metrics
Currency in CNY
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Debt to Assets